Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 04/30/2026 | 01/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -5.53% | -57.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.53% | -57.35% | |||
| Cost of Revenue | -39.55% | -49.50% | |||
| Gross Profit | 10.16% | -60.21% | |||
| SG&A Expenses | 13.26% | -55.12% | |||
| Depreciation & Amortization | -1.30% | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.78% | -51.06% | |||
| Operating Income | -18.09% | -18.49% | |||
| Income Before Tax | -216.99% | 72.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -216.99% | 72.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -216.99% | 72.38% | |||
| EBIT | -18.09% | -18.49% | |||
| EBITDA | -25.37% | 13.87% | |||
| EPS Basic | -250.00% | 75.00% | |||
| Normalized Basic EPS | -300.00% | 80.00% | |||
| EPS Diluted | -250.00% | 75.00% | |||
| Normalized Diluted EPS | -300.00% | 80.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||